User menu

Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial.

Bibliographic reference Scirica, Benjamin M ; Bonaca, Marc P ; Braunwald, Eugene ; De Ferrari, Gaetano M ; Isaza, Daniel ; et. al. Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial.. In: The Lancet, Vol. 380, no. 9850, p. 1317-24 (2012)
Permanent URL http://hdl.handle.net/2078.1/123463